In our cohort, plasma concentrations of cPLA2 did not discriminate between the COVID‐19 versus non‐COVID‐19 sepsis patients, while PLA2G2D was lower in the COVID‐19 patients than in both the non‐COVID sepsis group and the healthy controls (Figures S1B and C). This evidence concerns the gene PLA2G4A and COVID-19.